New pill shows promise for tough blood cancers
Disease control
Recruiting now
This study tests an experimental drug called CTX-712 in people with acute myeloid leukemia (AML) or myelodysplastic syndromes (MDS) that have come back or not responded to treatment. The drug is taken by mouth once or twice weekly. The trial aims to find the safest dose and see i…
Phase: PHASE1, PHASE2 • Sponsor: Chordia Therapeutics, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:06 UTC